Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function (Q40951718)

25 September 2017

title

Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function (English)

1 reference

25 September 2017

main subject

transmembrane protein

0 references

1 reference

1 reference

25 September 2017

1 reference

25 September 2017

Shirakawa AK

1 reference

25 September 2017

Turpin JA

1 reference

25 September 2017

Maynard A

1 reference

25 September 2017

Tobin GJ

1 reference

25 September 2017

Carrington M

1 reference

25 September 2017

Oppenheim JJ

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Journal of Biological Chemistry

25 September 2017

published in

1 reference

25 September 2017

volume

274

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

16228-16234

1 reference

Co-receptors for HIV-1 entry

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

HIV entry and its inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Novel alleles of the chemokine-receptor gene CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Structural domains of interleukin-2 receptor beta critical for signal transduction: kinase association and nuclear complex-formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Monocyte Chemotactic Protein-2 Activates CCR5 and Blocks CD4/CCR5-mediated HIV-1 Entry/Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

The second extracellular loop of CCR5 is the major determinant of ligand specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Determinants of HIV-1 coreceptor function on CC chemokine receptor 3. Importance of both extracellular and transmembrane/cytoplasmic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Close association of the first and fourth extracellular domains of the Duffy antigen/receptor for chemokines by a disulfide bond is required for ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1, CCR-3, and CCR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Distinct but Overlapping Epitopes for the Interaction of a CC-Chemokine with CCR1, CCR3, and CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Regulatory mechanisms that modulate signalling by G-protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.23.16228

21 January 2018

Identifiers

DOI

10.1074/JBC.274.23.16228

1 reference

25 September 2017

1 reference